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Abstract
Background: Advances in mass spectrometry-based proteomics have enabled the incorporation of proteomic data into
systems approaches to biology. However, development of analytical methods has lagged behind. Here we describe an
empirical Bayes framework for quantitative proteomics data analysis. The method provides a statistical description of each
experiment, including the number of proteins that differ in abundance between 2 samples, the experiment’s statistical
power to detect them, and the false-positive probability of each protein.
Methodology/Principal Findings: We analyzed 2 types of mass spectrometric experiments. First, we showed that the
method identified the protein targets of small-molecules in affinity purification experiments with high precision. Second, we
re-analyzed a mass spectrometric data set designed to identify proteins regulated by microRNAs. Our results were
supported by sequence analysis of the 39 UTR regions of predicted target genes, and we found that the previously reported
conclusion that a large fraction of the proteome is regulated by microRNAs was not supported by our statistical analysis of
the data.
Conclusions/Significance: Our results highlight the importance of rigorous statistical analysis of proteomic data, and the
method described here provides a statistical framework to robustly and reliably interpret such data.
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Introduction
Recent advances in mass spectrometry (MS)-based proteomics
technology have enabled the investigation of proteomes at a
systems level [1]. In particular, the ability to quantify relative
protein abundance in 2 samples has made possible a plethora of
proteome-wide studies including characterization of proteins or
phospho-proteins that differ between 2 phenotypic states [2],
measurement of changes in response to extracellular stimuli [3] or
microRNA over-expression [4,5], and analysis of sub-proteomes
detected by affinity capture methods to study protein-protein
interactions [6], protein phosphorylation dynamics [7–9], or
identification of small-molecule targets [10]. Despite the immense
potential and increasingly widespread application of quantitative
proteomics, comparably little attention has been devoted to the
analytical challenges of accurately interpreting the data and
understanding the capabilities and limitations of experiments.
While several alternative approaches exist, in this work we focus
on SILAC experiments [11], in which isotopically-labeled amino
acids enable peptides arising from 2 different samples to be
distinguishable by MS (Figure 1). A quantitative measure of
differential peptide abundance is then calculated as the ratio of
extracted ion intensities (XICs) between the 2 samples. A number
of analytical challenges must be addressed to reliably interpret
such data. In particular, analysis of mass spectra to identify peaks
and map peptide sequences to proteins has been well-studied in
traditional proteomics applications, and good software packages
exist for generating peptide XIC ratios [12–14]. Moreover, several
methods have been proposed for data normalization [15] and
summarization of protein ratios, including averaging [13] or
intensity-weighted averaging [16] of ratios for peptides identifying
the same protein. However, a critical issue that remains less well-
addressed is the development of statistical models to identify
biologically relevant proteins based on SILAC ratio values
summarized at the protein level (e.g. the median XIC ratio for
all peptides identifying a protein, generally log transformed to treat
over- and under-abundance symmetrically) [17,18]. Such statisti-
cal estimates are critical since variations in relative abundance
measurements arise from confounding factors such as spectral
background noise, interfering signals from co-eluting peptides,
differential lysis efficiencies, isotope impurities, and incomplete
incorporation of the isotope label. Moreover, changes in detection
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7454Figure 1. Schematics of SILAC-based experiments analyzed in our study. (A) Small-molecule target identification workflow, as described in
[30]. HeLa S3 cells were cultured in ‘‘heavy’’ medium, containing amino acids enriched in stable isotopes (
13C and
15N), and ‘‘light’’ medium
containing forms of natural isotope abundance. Both the heavy and light lysates were incubated with small-molecule loaded beads (referred to as the
affinity matrix) while the light lysate contained the addition of a soluble form of the small-molecule that competed with the affinity matrix for binding
to target proteins. The red ovals represent a target protein that was bound to all 3 small-molecule loaded beads shown in this schematic for the
heavy lysate, but was competed off of 2 of the 3 beads in the light lysate. The green pentagons represent a protein that bound non-specifically to the
beads in both the heavy and light lysates. Proteins bound to the affinity matrix were enriched by affinity pull-down, their relative abundances were
quantified by LC-MS/MS, and targets were identified by analyzing the resulting abundance ratios, XICheavy
 
XIClight, using the empirical Bayes
framework described in the text. (B) microRNA workflow, as described in [4]. HeLa cells were transfected with microRNAs or mock-transfected, and
pulse-labeled after 8 hours with ‘‘medium’’ or ‘‘heavy’’ amino acid isotopes. After 24 hours, samples were combined and analyzed by LC-MS/MS. The
red ovals represent a protein regulated by the microRNA that was depleted in the medium lysate, and the green pentagons represent an unregulated
protein of equal abundance in both lysates. (C) Two affinity pull-down experiments performed at different soluble competitor concentrations of the
protein kinase inhibitor k252a displayed distinct variances of log2 SILAC ratio distributions. Applying a commonly used threshold of 1.5-fold (log2
threshold of .58) to identify significant proteins inferred 66 non-kinases (indicative of false-positives) for the high-variance experiment compared to
11 for the low-variance experiment, suggesting the necessity of experiment-specific models. (inset) The red curve represents the same k252a
experiment, performed at .25x concentration, as displayed in the main plot, and the grey curve represents a replicate performed on the same cellular
lysate with the same k252a concentration. This replicate experiment displayed a shift in the overall distribution due to non 1-to-1 mixing of heavy and
light samples, which should be accounted for by appropriate normalization.
doi:10.1371/journal.pone.0007454.g001
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samples may produce differences in technical or experimental
variation (Figure 1c). Such quantitative errors must be appropri-
ately modeled to identify ratio values attributable to true
differential abundance.
Previous studies analyzing quantitative proteomics data often
rely on techniques such as applying a universal fold-change
threshold [7,11], which does not account for experiment-specific
differences (Figure 1c), or fitting a distribution to all ratio values
[19,20], which does not appropriately isolate only the null
distribution statistics. Standard methods such as Bonferroni
correction or q-value calculation have been applied to correct
for multiple tests [14,21,22], but have been observed to be overly
conservative, often computing no observations as statistically
significant. Other methods require large numbers of replicates to
calculate t-test p-values or to determine binding response curves at
a range of soluble competitor concentrations [10]. Other methods,
based on spectrum counting [23], are limited in their ability to
detect low abundance proteins.
In this work, we explored the application of empirical Bayes
modeling of SILAC experiments. We began by testing previously
proposed methods. These include Gaussian mixture models, a
type of empirical Bayes method that has been applied to
quantitative proteomics data [24–27], as well as the approaches
developed by Efron [28,29] in the context of gene expression
analysis. We found that these methods could not robustly model
experimental data that contained non-Gaussian tails or regions of
data sparsity, and therefore proposed a new method that more
robustly fit the SILAC experimental data analyzed in our study.
We then proposed multivariate statistics that integrate the results
from multiple replicate experiments to compute false discovery
rates, the total number of differentally abundant proteins, and
statistical power.
In summary, our method models log2 SILAC protein ratio
values from 1 or multiple replicate experiments and infers the full
shape of class-conditional probability distributions for biologically
relevant proteins (i.e. those that differ in abundance between the 2
samples) versus background. In addition to inferring the false-
positive probability of each protein, the method also provides a
framework to reason about inference problems not previously
addressed in quantitative proteomics, such as the total number of
proteins likely to be of biological relevance and the experiment’s
statistical power to detect them. We applied the method to detect
protein targets of small-molecules based on affinity pull-down
experiments and to identify differentially regulated proteins after
microRNA over-expression or repression.
Results
Evalutation of previous empirical Bayes methods
Empirical Bayes methods have been used in several quantitative
proteomics studies, as well as in the related field of gene expression
analysis. In particular, Gaussian mixture models are a standard
and straightforward approach that has been used to model
quantitative proteomics experiments [24–27]. However, by
assuming that the data arise from a mixture of Gaussian
distributions, this approach is not robust to outlier data points,
and we found that such methods failed to generate plausible
statistical models of the experiments considered in our study
(Figure 2), which contained significantly non-Gaussian tails. We
therefore motivated our approach by extending the empirical
Bayes framework of Efron [28,29], which was developed in the
context of gene expression analysis and overcomes the constraints
of the Gaussian mixture model by allowing more flexible modeling
of the data. Briefly, this method begins by estimating the empirical
marginal distribution of all data, and then estimating the portion
of this distribution inferred to arise from technical and
experimental variation (i.e. the null distribution). We found that
proposed methods for inferring the marginal distribution,
including Poisson regression models or natural splines [28],
tended to over-fit the data considered in our study, which
contained regions of data sparsity at the tails (Figure S1). We
therefore implemented an approach that fits a flexible model to the
dense central data region, but constrains the tails to be fit by a
parametric model (see Methods). We then further extended the
method of Efron by developing a multivariate model able to
handle replicate experiments. That is, the method of Efron was
developed to model a summarized test statistic (e.g. z-scores)
derived from multiple experiments. For quantitative proteomics
data, where each experiment measures ratio values from paired
case-control samples, it is more appropriate to model each
experiment separately and subsequently integrate the statistics.
We therefore developed an approach in which experiment-specific
models are combined to compute false discovery rates, the total
number of differentially abundant proteins, and statistical power
given the results of multiple experiments (see Methods).
Application to small-molecule protein target
identification
We first evaluated our methodology’s ability to accurately
identify the protein targets of small-molecules based on liquid
chromatography tandem mass spectrometry (LC-MS/MS) relative
protein abundance measurements derived from affinity pull-downs
using SILAC-labeled HeLa S3 lysates (Figure 1a) [30]. We
analyzed experiments using 2 different kinase inhibitor com-
pounds and a control experiment in which ‘heavy’ and ‘light’
labeled cells were processed under identical conditions. For each
experiment, the accuracy of our analytical method in recovering
known targets was assessed. We note that, as with most discovery
methods, gold standards are inherently imperfect as it is likely that
not all target proteins of each compound have been characterized.
However, we attempted to select kinase inhibitors that have been
well-studied in the literature, providing as objective an evaluation
framework as we could devise.
To assess the false-positive rate of our analysis procedure we first
performed a control experiment, in duplicate, in which both
samples were incubated with an affinity matrix loaded with the
immunophilin-modulating compound AP-1497, but no soluble
competitor was added. For each protein, we calculated the false-
positive probability (see Methods), also called the local fdr (by
convention, we write local fdr in lowercase to distinguish it from
the more commonly used FDR, which is calculated based on tail
areas). The local fdr calculation correctly predicted no specifically
bound targets in these control experiments (all proteins were
assigned a local fdr of 1), suggesting the high precision of the
method. We benchmarked our method against 2 commonly used
analysis strategies, not including the Gaussian mixture model
approach [24–27], which produced uninterpretable results for our
experiments (Figure 2). The first benchmark method used a
universal fold-change threshold for determining significance. Two
studies evaluated reproducibility using a number of analytical and
experimental approaches to determine that fold-change cut-offs of
1.3 [6] or 1.5 [7] in either replicate experiment reliably eliminated
analytical errors. We used the 1.5 ratio cut-off, which produced
better results for our experiments. This approach identified 5
proteins passing the fold-change criteria, suggesting that such
methods likely incur false-positives. The second benchmark
method used a Gaussian error model to determine significance
Empirical Bayes for Proteomics
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correction and other conservative approaches to correct for
multiple hypotheses, and we observed that such approaches often
eliminated all proteins as being non-significant, consistent with
previously reported findings [21]. To avoid such overly-conserva-
tive corrections and to enable direct comparison with our method,
we computed false-positive probabilities for each log2 SILAC ratio
based on q-values [31] computed from the Gaussian error model
(see Methods). The Gaussian method also correctly predicted zero
significant targets in the control experiments.
We next tested our ability to identify the protein targets for
broad-specificity compounds. We performed replicate experiments
at soluble competitor concentrations of 0.025x, 0.25x, 2.5x, 5x,
and 10x of k252a, a staurosporine analog that binds broadly to
protein kinases. In this experimental design, the soluble competitor
should compete proteins specifically bound by k252a off of the
affinity matrix in the light sample, but non-specific binders should
remain, causing k252a target proteins to be distinguishable by high
SILAC ratios (Figure 1a). We evaluated our predictions with
respect to known human protein kinases [32]. This analysis
indicated that our method achieved high precision in discrimi-
nating kinases from non-kinases (Figure 3 and Table 1). For each
of the 4 experiments performed at higher soluble competitor
concentrations, over 86% of the inferred targets (local fdr cut-off
.01) were protein kinases, with up to 41 kinases inferred as targets
(Table 1). In addition, the validity of multiple non-protein-kinases
inferred as targets was supported by additional evidence. For
example, 4 non-kinases were identified as targets in the 10x
experiment: TPRKB and CCNB1 form complexes with the
protein kinases TP53RK and CDC2, respectively, both of which
were identified as k252a targets; a third non-kinase inferred target,
the oxidoreductase NQO2, has recently been demonstrated to
bind specifically to the kinase inhibitor imatinib [10]; and the
fourth non-kinase target, OSGEP, is a novel prediction, and was
identified at both the 5x and 10x soluble competitor concentra-
tions, suggesting that this was a reproducible finding. The
complete list of predicted targets for each experiment using each
analysis method is given in Table S1.
In comparison, the Gaussian model identified only the highest
confidence interactions, yielding a maximum of 5 predicted targets
in any of the experiments (cut-off .01). We note that even relaxing
the cut-off to .2 would produce only 12 and 21 predicted targets
for the 5x and 10x experiments, respectively. Interestingly,
although the proteins identified as significant by our method for
the 5x and 10x experiments were largely in agreement with the 1.5
ratio threshold determined by Blagoev et al. [7], the 1.5 threshold
yielded dramatically more false-positives for the 3 experiments at
lower concentrations (Figure 4a and Table S1). Empirical Bayes
Figure 2. Statistical models of single-replicate experiments. For representative experiments corresponding to the 2 data modalities
considered in our study (affinity pull-down and microRNA), we display the results of applying a Gaussian mixture model (following the approach of
Marelli et al. [26]) and our empirical Bayes method. (A) Comparative models of an affinity pull-down experiment. The left panel displays an idealized
representation of the desired modeling result, which distinguishes separate distributions corresponding to unenriched proteins (log2 ratio around 0)
and enriched proteins (positive log2 ratios). The Gaussian mixture model failed to generate a plausible model of the experimental data (white bars)
and instead represented enriched proteins using a very high-variance Gaussian (green curve) to explain the large number of data points that were
not explained by the central Gaussian (red curve). Using this model, negative-ratio proteins were erroneously inferred to have a higher probability of
being enriched than positive-ratio proteins. By contrast, our model correctly inferred a distribution of positive ratio values corresponding to enriched
proteins, with the null distribution correctly accounting for the unenriched proteins. (B) Comparative models of a microRNA experiment. The left
panel displays an idealized model that distinguishes separate distributions corresponding to proteins that are non-regulated, up-regulated, or down-
regulated upon microRNA over-expression. The Gaussian mixture model failed to generate a plausible model, and instead inferred 2 distributions
centered around zero, with a third high-variance distribution to explain the outliers (distributions are labeled as down-regulated, non-regulated, and
up-regulated in order of their means). By contrast, our method generated a model consistent with the desired 3 distributions of down-regulated,
non-regulated, and up-regulated proteins. The modeling results shown here are representative of all experiments considered in our study.
doi:10.1371/journal.pone.0007454.g002
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discriminatory boundaries near a ratio of 1.5; however, the 3 lower
concentration experiments, which were performed on a different
set of lysates from a separate culture of cells, displayed more
experimental variability (Figure 1c), and our model predicted a
corresponding increase in the significance thresholds (Figure 3).
Indeed, the majority of proteins identified in the 3 lower
concentration experiments using the 1.5 ratio cut-off, but not
significant by our model, showed no evidence of being associated
with kinase biology, supporting the use of models such as ours to
capture experiment-specific variability.
Having demonstrated that the local fdr statistic reliably
produced a low false-positive rate for the k252a experiments, we
then evaluated whether statistical power diagnostics could be used
to reason about the expected false-negative rate. Our analysis
predicted that statistical power increased with increasing k252a
soluble competitor concentration, and, consistent with this
prediction, the percent of kinases detected by LC-MS/MS that
were statistically significant (recall) also increased (Figure 4b). For
the 5x and 10x experiments, we predicted near 100% statistical
power, in agreement with our gold standard comparison (Figure 3),
which showed that protein kinases (red diamonds) were well-
Figure 3. Empirical Bayes model applied to replicate k252a experiments. Scatter plots display log2 SILAC ratio values for replicate
experiments performed using k252a. Plots are arranged in order of increasing soluble competitor concentration. Contour lines display the predicted
probability of binding k252, Pr Z~1jX1,X2   
, ranging from 99.9% to 75% from outermost to innermost. Red diamonds represent protein kinases,
green squares represent proteins known to exist in complex with a protein kinase that was identified as a k252a target, and blue circles represent all
other proteins.
doi:10.1371/journal.pone.0007454.g003
Table 1. Evaluation of predicted small-molecule targets.
Small-molecule Concentration Total detected Known targets detected Total significant Known targets significant Precision Recall
k252a .025x 584 42 3 0 0% 0%
k252a .25x 697 55 15 13 87% 24%
k252a 2.5x 530 36 29 25 86% 69%
k252a 5x 637 47 46 41 89% 87%
k252a 10x 540 43 43 39 91% 91%
SB-202190 10x/100x 276 6 10 6 60% 100%
AP-1497 0x 514 0 0 0 N/A N/A
For each experiment we evaluated the list of targets inferred by our model compared to a list of known targets, defined for k252a as human protein kinases [32] and for
SB-202190 as those identified by Karaman et al. [33]. ‘‘Detected’’ refers to all proteins detected by LC-MS/MS and ‘‘significant’’ refers to those inferred as significant by
our model (local fdr threshold .01). Precision was calculated as the percent of proteins inferred as significant by our model that were also known targets, and recall was
calculated as the percent of known targets detected by LC-MS/MS that were also inferred as significant by our model. Because our lists of known targets were
incomplete, precision statistics were likely underestimated. Targets with additional evidence of binding each small-molecule are annotated in Table S1.
doi:10.1371/journal.pone.0007454.t001
Empirical Bayes for Proteomics
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7454separated from non-protein-kinases (blue dots). Statistical power
decreased with decreasing soluble competitor concentration,
indicating that the SILAC ratio sub-distribution derived from
target proteins merged with the sub-distribution derived from non-
specific binding proteins, consistent with the observation that
SILAC ratios of protein kinases began to overlap with those of
non-protein kinases (Figure 3).
Interestingly, our model inferred roughly the same total number
of targets in the 2.5x experiment as for the higher concentrations
(Table S1), but predicted that the 2.5x experiment had reduced
power to reliably detect them, correctly describing the fact that
roughly the same total number of kinases were detected by
LC-MS/MS at each of these concentrations, but many of these
kinases could not be robustly separated from the background at
2.5x concentration. At the very low concentrations (.25x and
.025x) both the total number of inferred targets and statistical
power were reduced, as the SILAC ratios for some kinases showed
no enrichment towards positive values (Figure 3). Our model also
predicted that, for all experiments considered here, substantial
statistical power was gained by performing replicate experiments,
as the bivariate class-conditional probability distributions of
SILAC ratios from targets versus non-targets were more robustly
separated than those from single experiments (Figure 5).
Overall, these results suggested that the experimental method-
ology, and associated statistical model, provided high precision in
identifying small-molecule targets with a low false-positive rate.
Increasing the soluble competitor concentration led to identifica-
tion of more true targets without an associated increase in false-
positives. These conclusions were supported by comparison with
our list of protein kinases, but we stress that, absent a gold
standard list, the empirical Bayes methodology and power
diagnostic accurately described these features of the experiments
from statistical modeling of the data alone.
We next examined our ability to correctly detect targets of a more
specific small-molecule. We tested SB-202190, a kinase inhibitor of
MAPK14 (also known as p38). This compound was recently
evaluated in an in vitro competition assay against a panel of 287
distinct human protein kinases, representing ,55% of the predicted
human protein kinome [33], and the authors detected 39 targets of
SB-202190 with KD,10 mM. Based on our conclusions from the
k252a analysis, we performed single SILAC experiments using
soluble competitor concentrations of 10x and 100x and applied our
statistical model to assess the probability that each detectable protein
was bound by SB-202190 given these 2 SILAC ratios. Only 6 of the
39 targets reported by Karaman et al. were detectable by LC-MS/
MS in our pull-down experiments (including MAPK14), and all 6 of
these proteins were significant using the local fdr cut-off of .01
(Table 1). Four additional targets – TGFBR1, CSNK1A1, CHD6
and FAM83G – were also identified at this threshold. TGFBR1 was
tested in the study of Karaman et al. but not reported as bound by
SB-202190. However, it was reported as a low affinity (7.1 mM)
binder of the closely related and structurally similar SB-431542,
which showed an extremely similar binding profile to SB-202190 in
this experiment. It is therefore likely that TGFBR1 also binds with
low affinity to SB-202190 but was not detected at the threshold of
10 mM used in this study. CSNK1A1 was not tested by Karaman et
al.,but 3 related proteins– CSNK1A1L,CSNK1D,and CSNK1E–
were tested and all found to bind SB-202190. CHD6 and FAM83G
are not kinases and therefore were not tested by Karaman et al.,
although CHD6 is known to bind ATP [34] suggesting that it may
also bind kinase inhibitors, which interact with ATP-binding
domains of protein kinases. The calculated power statistic for this
experiment was .99%, indicating that the inferred sub-distribution
arising from target proteins was completely separated from the
inferred null distribution, supporting our conclusion from the k252a
experiments at higher soluble competitor concentrations, and in
agreement with the statistical significance of all proteins identified by
Karamanetal.andalsodetectedbyLC-MS/MS.Incomparison,the
Gaussian model eliminated all targets as non-significant, while the
fold-change method inferred the same 10 targets as our method, but
also inferred an additional 8 targets, none of which have evidence of
binding SB-202190 (Figure 4a and Table S1).
Application to microRNA experiments
Having demonstrated our method’s utility for small-molecule
protein target identification experiments, we sought to evaluate its
Figure 4. Evaluation of methods applied to affinity pull-down experiments. (A) For each experiment we calculated the total number of
errors (false-positives plus false-negatives) based on each analysis method, defining known targets for k252a as human protein kinases [32] and for
SB-202190 as targets identified by Karaman et al. [33]. Zero targets should be identified for the control experiment (AP-1497, no soluble competitor),
thus the total errors are the number of identified proteins. These comparisons consistently illustrated the superior performance of our method. (B)
Increased statistical power correlated with the percent of known targets identified as significant by our model (recall).
doi:10.1371/journal.pone.0007454.g004
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experiments. We therefore applied the statistical method to the
analysis of a recent study by Selbach et al. [4] that used pSILAC (a
variant of SILAC used to measure only newly synthesized
proteins, rather than total protein abundance) to identify proteins
differentially regulated upon microRNA over-expression or
repression (Figure 1b).
To evaluate whether proteins differentially regulated by
microRNA over-expression or repression could be accurately
identified using our empirical Bayes strategy, we applied our
model to assign a probability that each protein is differentially
regulated in the 6 experiments performed by Selbach et al.T h e s e
include over-expression of human microRNAs miR-1, miR-155,
let-7b, miR-16, and miR-30a and knockdown of let-7b,
performed in single replicate. Analogous to the small-molecule
target identification application, we assumed a 3-class model of
SILAC ratio values, in this case representing proteins up-
regulated, down-regulated, and not differentially regulated upon
microRNA over-expression or repression. In contrast to the
conclusion of Selbach et al. that each of the 5 tested microRNAs
regulated most of the &3,000 proteins detected in the
corresponding experiment, our analysis indicated that only
between 5 and 13 percent of proteins detected in each
experiment were down-regulated by microRNA over-expression
(or up-regulated by knockdown). The statistical power for each
experiment ranged from 63.8% to 76.5%, indicating that the full
range of differentially regulated proteins could not reliably be
detected (Table S2). We stress that even for underpowered
experiments, the total number of differentially expressed proteins
can still be inferred (see Eqn. (4) in Methods).
We evaluated the accuracy of our predictions by considering
microRNA seed sequence enrichments in the 39 UTRs of mRNAs
corresponding to predicted differentially regulated proteins.
Directly relating the accuracy of predicted targets to seed sequence
enrichments is challenging, because the presence of a seed
sequence is not directly predictive of microRNA regulation, and
differentially regulated proteins may contain a mixture of those
directly targeted by the microRNA as well as secondary effects. In
effect, the presence of a seed sequence is a noisy indicator of
differential expression upon microRNA over-expression or
repression. However, we may evaluate our predictions with
respect to this noisy indicator by using the strategy employed by
Margolin et al. [35]. That is, we may evaluate the enrichment of
seed sequences as a function of the local fdr threshold, compared
to a set of proteins unlikely to be regulated by the microRNA,
providing a standardized benchmark quantity for all experiments,
irrespective of background site enrichment. We expected that
proteins inferred as non-significant by our model would show no
enrichment in the corresponding microRNA seed sequence while
those identified with high-confidence as being differentially
regulated would be enriched in seed sequences, even if some
indirectly regulated proteins were included as well.
Our analysis indicated that, in general, empirical Bayes
predictions were in quantitative agreement with seed sequence
enrichment analysis, thus validating our findings (Figure 6a).
Proteins with ratio values predicted by our model to represent
experimental variation rather than true differential regulation (i.e.
those with near zero probability of significance), showed no
enrichment in microRNA seed sequences. As the predicted
probability of differential regulation increased, we observed a
Figure 5. Increased statistical power from replicate experiments. Modeling of class-conditional probability distributions allows statistical
reasoning about the power of an experiment. (A) Inferred distributions from individual replicate experiments of k252a at 2.5x concentration showed
that the distribution arising from target proteins (green curve), Pr(X|Z=1)Pr(Z=1), had significant overlap with the inferred null distribution (red
curve), Pr(X|Z=0)Pr(Z=0), corresponding to power statistics of 75.6% and 83.4%, respectively for the top and bottom plots. (B) Theoretical modeling
of the inferred bivariate class-conditional probability distributions from replicate experiments showed that the distribution arising from target
proteins (solid curve), Pr X1,X2jZ~1
  
, was well-separated from the inferred null distribution (mesh curve), Pr X1,X2jZ~0
  
, corresponding to an
increased power statistic of 91.5%. For ease of visualization, bivariate class-conditional probability distributions are not scaled by their prior
probabilities.
doi:10.1371/journal.pone.0007454.g005
Empirical Bayes for Proteomics
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all proteins in the high-confidence range being highly enriched. In
contrast, the Gaussian method and the fold-change method both
inferred as non-significant the majority target proteins. We
estimated that the 1.5 ratio cut-off eliminated at least two-thirds
of truly differentially regulated proteins in 5 of the 6 experiments
(Table S2). To obtain a larger list of putative targets, Selbach et al.
compiled a list of proteins with log2 SILAC ratios less than 2.1 (or
greater than .1 for the knockdown experiment). Our analysis
predicted that more than half of all proteins identified using this
threshold were likely to be false-positives (Table S2). Supporting
this observation, the 200 proteins with the largest log2 SILAC
Figure 6. Empirical Bayes analysis of microRNA experiments. (A) For single replicate models, microRNA seed sequence enrichments (blue
curve) corresponded with inferred probabilities of differential regulation computed by the empirical Bayes method (red curve), while Gaussian error
modeling (green curve) eliminated the majority of regulated proteins. Sequence analysis was performed using bins of fifty proteins (plotted at the
mid-point of each bin) sorted by ascending SILAC ratios, and computing the p-value of microRNA seed sequence (positions 2–8) enrichment, based
on the hypergeometric distribution, against a background of the one-third of proteins with the largest SILAC ratios (or lowest ratios for the let-7b
knockdown experiment). Similar results were obtained using different bin and background sizes, as well as different seed sequence definitions or
algorithmically predicted targets (Figure S5). (B) Log2 SILAC ratios from the let-7b over-expression experiment were plotted against log2 SILAC ratios
from the let-7b knockdown experiment. Colors indicate the percent of predicted targets, using the Target Scan algorithm [36], for each pair of ratio
values, averaged over the 100 nearest neighbors by Euclidean distance. Only proteins inferred as significantly down-regulated upon let-7b over-
expression and up-regulated upon let-7b knockdown (dotted blue curve) appeared enriched in let-7b target sites. (C) Data points display the same
scatter plot as in (B), with contour lines representing inferred probabilities of differential regulation (assuming significant proteins move in opposite
directions upon let-7b over-expression or knockdown). For each of the 225 regions in an evenly spaced grid over the plot’s domain, we randomly
selected a percent of proteins according to the inferred probability of differential regulation (red points). These proteins are representative of those
inferred to be regulated by let-7b. The overall data displayed a large negative correlation (t=2.28), but the correlation based only on inferred non-
regulated proteins was reduced to t=2.06. We used Kendall’s t rank correlation coefficient to provide robustness against potential outlier points
that would be eliminated only from the upper-left and lower-right quadrants of the plot, and therefore overstate our finding by reducing Pearson
correlation to near zero.
doi:10.1371/journal.pone.0007454.g006
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knockdown experiment) were not statistically significantly enriched
in microRNA seed sequences (P..05 for all experiments).
Interestingly, the authors of this study observed an overall
negative slope of ratio values in the let-7b over-expression versus
repression experiments, suggesting that let-7b may globally
regulate the production of most of the &3,000 proteins detected
in the experiments, in contrast to our prediction that only several
hundred proteins are regulated in each experiment. We therefore
applied our model to assess the probability that each protein is up-
regulated upon let-7b knockdown and down-regulated upon let-7b
over-expression (or down-regulated upon knockdown and up-
regulated upon over-expression). Consistent with our observation
from the affinity pull-down experiments, when considering both
the over-expression and knockdown experiments together, statis-
tical power was increased to 88.4% (compared to 68.1% and
67.1% for each experiment considered individually). Moreover, in
agreement with our model, we observed that only proteins in the
statistically significant region were enriched in let-7b targets
predicted by the TargetScan algorithm [36](Figure 6b). While
the remaining proteins may indeed be regulated by non-seed
mediated mechanisms, we suggest an alternate possibility that a
limited number of differentially regulated proteins (including those
up-regulated upon over-expression and down-regulated upon
knockdown) may display ratio values that overlap with those of
non-regulated proteins, influencing the overall slope of the scatter
plot. Consistent with this hypothesis, computing the slope based
only on inferred non-regulated proteins (by eliminating data points
in proportion to their inferred probability of regulation) reduced
Kendall’s t correlation coefficient from .28 to .06 (Figure 6c).
Although suggestive, we recognize that sequence enrichment
analysis does not constitute proof of our hypothesis, and specific
follow-up experiments are necessary to validate the full range of
let-7b targets. However, our results, taken together, indicate that
the data may not support the contention that let-7b globally
regulates protein production, as previously suggested [4].
Discussion
Modern high-throughput technologies in experimental biology
produce large-scale data sets consisting of hundreds or thousands
of measurements, presenting simultaneous inference challenges
not anticipated by classical statistical methods that were designed
for problems with small numbers of data points and limited
computational power. Commensurate advances in statistical
inference methods are required to maximally exploit the
information generated by this technological revolution. The past
decade has thus seen a flourishing of novel statistical and
computational methodologies (and resurrection of underdeveloped
methodologies) designed to tackle large-scale simultaneous infer-
ence tasks, as epitomized by gene expression micorarrays, but
extending to many other high-throughput technologies. Quanti-
tative proteomics methods are only recently becoming viable in
large-scale and can benefit from standardized analysis methods
built from the advances made in related statistical inference
problems.
Although empirical Bayes methods have been explored in
proteomics analysis, and have been well-studied in related fields
such as gene expression analysis, several modifications improved
their ability to model the SILAC experiments considered in our
study. In particular, the Gaussian mixture model approaches that
were previously used in proteomics applications were not robust to
experiments with non-Gaussian tails, whereas the density
estimation methods developed for gene expression analysis tended
to over-fit regions of data sparsity. We therefore modified the
method proposed by Efron to obtain more robust models of the
experimental data analyzed in this paper. We further extended the
method of Efron to facilitate its application to quantitative
proteomics experiments by developing multivariate statistics that
integrate the results of experiment-specific models of multiple
replicate experiments to compute false discovery rates, statistical
power, and the total number of differentially abundant proteins.
Overall, we believe that empirical Bayes methods, and the
particular novel aspects described in this work, will be a powerful
addition to the analytical approaches to quantitative proteomics
experiments. Empirical Bayes methods are designed to leverage
aspects of both Bayesian and frequentist statistical inference by
using the powerful and flexible reasoning tools of Bayesian
statistics, but exploiting the massively parallel structure of the data
to infer prior probability distributions in a frequentist-type setting.
This data-driven approach relies on minimal assumptions and
enables transparent and consistent inference of class-conditional
probability distributions, using a highly flexible model of the
marginal and a Gaussian model of the null distribution. While the
null distribution model may produce some inaccuracies for data
with significantly non-Gaussian tails, we note that the 2-class
model is unidentifiable without restrictions on the form of this
distribution [37], and Gaussian distributions are widely used in
error modeling. For the experiments considered here our analysis
indicated that use of a Gaussian model did not produce significant
errors, as zero proteins were significant in the control experiment
with no soluble competitor, and the models of the other affinity
pull-down experiments appeared to yield very low false-positive
rates.
The Bayesian construction enables a principled framework that
encompasses a number of inference tasks about the data and can
be used both to predict significant observations (e.g. small-
molecule targets) and reason about the capabilities and limitations
of an experiment (e.g. statistical power). We believe these tools can
be used to guide experimental design and inform follow-up
experiments in a cost-effective manner. We have demonstrated the
use of power analysis of various affinity pull-down experiments to
suggest high soluble competitor concentration and replicate
experiments as the optimal experimental design, predicted to
yield near 100% statistical power. Consistent with this prediction,
our models of the high-concentration replicate experiments for
both k252a and SB-202190 appeared to yield near optimal
discrimination of known targets versus non-targets that were
detected by LC-MS/MS. The prediction that nearly all detected
targets could be reliably identified as significant by our model
indicated that the dominant cause of false-negatives was likely
proteins not detected by LC-MS/MS. This analysis suggests that
further experimental improvements should focus on increasing the
number of detected proteins, for example by increasing the
amount of input protein, the amount of small-molecule loaded
onto the affinity matrix, or the sample fractionation.
Our statistical descriptions of the microRNA experiments were
different from those of the affinity pull-down experiments. We
predicted that several hundred proteins were differentially
regulated in each microRNA experiment. However, because the
magnitude of regulation was subtle, not all differentially regulated
proteins could be reliably separated from the experimental
variation, yielding sub-optimal power diagnostics. We believe that
such a precise description of an experiment has useful implications
for understanding the underlying biology. For example, our
observation that some microRNA targets were only subtly
regulated is significant considering recent evidence that such
subtle regulatory changes can have large phenotypic effects [38].
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regulated proteins are important for follow-up investigation;
however, the underpowered nature of the microRNA experiments
indicated that all regulated proteins could not be identified without
encountering a large number of false-positives (as can be predicted
by the local fdr statistic). The Bayesian inference framework
enables natural incorporation of additional information, which we
suggest may be combined with the weak evidence provided by
underpowered experiments to increase the overall statistical
power. We demonstrated a simple example of increasing statistical
power by incorporating replicate experiments under the condi-
tional independence assumption, but additional data sources, as
well as prior information, may also be naturally integrated with
our methodology. For example, we suggest that our models of the
microRNA proteomics experiments may be integrated with
probabilistic models that predict microRNA targets based on
sequence analysis [39], into a unified probabilistic inference
framework that may achieve increased statistical power to reliably
discriminate the full range of microRNA targets. The power
diagnostic therefore provides a useful indicator of when incorpo-
ration of additional information may increase the utility of
predictions.
Although assessing the performance of an analytical method is
challenging when true gold standards are not known, several
criteria indicated the robust performance of our method for both
data types considered in our study. For the affinity pull-down
experiments our method correctly recovered kinase targets of
k252a, previously reported targets of SB-202190, and no targets in
the absence of soluble competitor. For the microRNA experi-
ments, our results were in agreement with seed-sequence
enrichment analysis. Finally, for both types of experiments, our
method produced more accurate models of the experimental data
than existing methods.
Although evaluation of our method’s general applicability will
require further studies, we believe that the minimal assumptions
and demonstrated robustness of our approach suggest that it
should generalize to other SILAC data sets similar to those
analyzed in our study. The strategy employed for the small-
molecule target identification experiments is similar to that of
several other applications that analyze affinity-purified sub-
proteomes from SILAC-labeled lysates, including to study
protein-protein interactions using recombinant protein baits [6];
protein-peptide interactions using synthetic peptide baits [12];
global kinome phosphoproteomics using kinase-selective baits [8];
or phosphotyrosine-dependent signalling using anti-phosphotyr-
osine antibody baits [7,9]. Moreover, the results obtained from
analysis of the microRNA experiments suggest that the method
should generalize to other experiments analyzing SILAC-labeled
lysates to identify proteins or phosphoproteins that differ in
abundance between 2 conditions, for example to compare
different phenotypes [2,24,40]; primary cells versus cell lines
[41]; or response to perturbation [3,42]. Although we only
considered SILAC-based experiments in this study, in principle
the method should also apply to analysis of experiments performed
using other stable isotope labeling strategies such as chemical
modification-based approaches using ICAT [43] or iTRAQ [44].
We believe that the analytical methodology developed here will
be a useful addition to the wealth of data that can be generated by
modern quantitative proteomics methods. In particular, the
coupling of quantitative proteomics with an appropriate statistical
framework appears to now make feasible the routine identification
of protein targets of small-molecules. This capability has the
potential to greatly enhance cell-based chemical biology screens,
where the protein targets of active compounds have often
remained unknown. More broadly, the availability of a general-
izable, statistically principled analytical framework for proteomic
analysis should facilitate the incorporation of proteomic data into
systems biology studies.
Methods
Statistical model
We describe our analytical method in the context of the affinity
pull-down experiments in SILAC labeled lysates (Figure 1a), but it
is applicable to any quantitative proteomics data set. The method
takes as input log2 SILAC protein ratio values, corresponding to
relative abundances, for 1 or multiple replicate experiments. In
our affinity pull-down data set we observed minimal increase in
the variance of ratio values at low intensities (Figure S2), and thus
summarize data at the protein level using the common strategy of
calculating the median log2 XIC ratio value across peptides
identifying the same protein [2], requiring at least 2 unique
peptide hits in any replicate experiment for confident protein
identification.
We formulate the inference task as one of binary classification
between small-molecule targets and non-targets (we assume non-
targets have low enough affinity for the soluble competitor to have
negligible effect on the SILAC ratio). We thus seek to compute the
Bayes posterior probability that a protein is not bound by the test
compound given the measured SILAC ratios from 1 or multiple
experiments. For a single experiment, this posterior probability is
called the local fdr [45]:
Pr Z~0jX ðÞ ~
Pr XjZ~0 ðÞ Pr Z~0 ðÞ
Pr X ðÞ
ð1Þ
where Z is a binary variable taking the value of zero if the protein is
not bound by the compound, and X is a measured log2 SILAC
ratio.Inthis2-classmodel,the probabilitythat aprotein isbound by
the test compound given the SILAC ratio is simply calculated as
Pr Z~1jX ðÞ ~1{Pr Z~0jX ðÞ . Inthe empiricalBayesframework,
the local probability models in Eqn. (1) are estimated from the data,
under the assumption of exchangeability. That is, that all proteins
have the same prior probabilities of being bound or unbound.
Pr(X), the denominator of Eqn. (1), defined as the marginal
distribution of all X’s, is estimated using all of the data in the
experiment. Approaches for estimating this distribution, proposed in
the context of microarray analysis, include fitting maximum likelihood
estimates of high-order polynomials [28] or mixture models [46,47].
However, it is difficult to apply these methods to the data considered
here since very few proteins may be bound by the compound, yielding
sparse data at the tails of the histogram, which tend to be over-fit by
models that allow too much flexibility (Figure S1). By contrast, data
arising from the unbound proteins are tightly centered around the
mixing ratio (log2 ratio close to zero), and can be estimated accurately
using flexible parametric or non-parametric methods. We therefore
infer the central part of the distribution using a Gaussian kernel
estimator, and fit the tails with generalized Pareto distributions.
Although other heavy-tail distributions could reasonably be applied as
well, generalized Pareto distributions were developed based on
theoretical arguments to accurately model the tails of a large number
of distributions [48], and we observed that this approach could
robustly model the different experiments considered in our study. In
this work, we fit the Pareto tails using log2 ratios +:5 from the mode
of the data, corresponding to the region where data was sparse.
Although this choice is arbitrary, we found that variations in this
parameter had negligible effect on the inference results, as the method
was robust over a large range of parameter choices (Figure S3). After
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the resulting piecewise distribution using a cubic spline to infer a
functional estimate of the complete marginal, Pr(X).
The numerator of Eqn. (1), Pr XjZ~0 ðÞ Pr Z~0 ðÞ , represents
the contribution to the marginal distribution arising from the
unbound proteins. Before describing estimation of this quantity,
we consider 2 differences between the data presented here and the
data used in empirical Bayes analysis of microarray experiments.
First, in the small-molecule target identification application, values
of interest only manifest as positive log2 ratios, requiring 1-tailed
significance tests. Second, values for unbound proteins may be
affected by several different processes. The majority of unbound
proteins have log2 ratios near zero, with deviations caused by
technical and experimental variation. There is often an additional
class of proteins, with distributions clearly separated from the first
class, that have negative log2 ratio values (Figure 7a, red box).
While the cause of these negative values is not fully known, they
may be due to proteins that precipitate out once the soluble
competitor concentration becomes too high. This hypothesis is
supported by our observation that these negative values corre-
spond to visual precipitation in the sample with soluble competitor
added. We note that they are not generally due to mass
spectrometry carryover and contaminants as they localize to
specific bands in our GeLCMS analysis, indicating that these
proteins were resolved in SDS-PAGE. Furthermore, differential
abundances of corresponding molecular weight proteins were also
observed in unmixed gel visualizations of the same pull-down
samples. Therefore, although we retain the form of Eqn. (1) for
consistency with the local fdr literature, in this application we
hypothesize a 3-class model (shown schematically in Figure 7a) in
which the numerator of Eqn. (1) is separated into 2 components:
Pr XjZ~0 ðÞ Pr Z~0 ðÞ ~Pr XjZ~0,Y~0 ðÞ Pr Z~0,Y~0 ðÞ
zPr XjZ~0,Y~1 ðÞ Pr Z~0,Y~1 ðÞ
where Y is a binary variable taking a value of zero if the
corresponding protein arises from the component of the null
distribution representing technical and experimental variation, and
a value of 1 if it arises from the component of the null distribution
with negative log2 ratio values not explained by technical and
experimental variation. We note that the same 3-class model also
applies to experiments designed to detect both significant positive
and negative ratio values, for example, the microRNA experiments
in which the 3 classes represent proteins up-regulated, down-
regulated and not differentially regulated. In this application, down-
regulated proteins would correspond to the class (Z=0,Y=1).
We next estimate each of these components. The term
Pr XjZ~0,Y~0 ðÞ Pr Z~0,Y~0 ðÞ corresponds to the null distri-
bution typically inferred in microarray local fdr applications and
can be estimated by making the ‘‘zero assumption’’ that the data
around the central peak of the histogram arises mostly from
proteins in this class (i.e. Z=0, Y=0). Assuming a Gaussian
distribution for the log2 ratio values of this class, we fit a quadratic
function to the central region of log Pr X ðÞ ðÞ [49]. Based on
previous estimates of experimental variability [50], in this work we
defined this central region as log2 ratios +:3 from the mode of the
data, and because the central region of the data was well fit by a
Gaussian (Figure 7b), we found that the fit was robust to the
amount of data used (Figure S3). For the microRNA experiments,
the null distribution was calculated using the central 50% of the
data (mean window size .22), and results were again robust over a
large range for this parameter (Figure S3). By construction, the
data around the central peak is assumed to arise from. Therefore,
the other 2 sub-distributions, Pr XjZ~0,Y~1 ðÞ Pr Z~0,Y~1 ðÞ
and Pr XjZ~1 ðÞ Pr Z~1 ðÞ are assumed to be completely separate
and arise, respectively, from data on the left and right side of the
central peak. Because the 3 sub-distributions are mutually
exclusive and exhaustive:
Pr XjZ~0,Y~1 ðÞ Pr Z~0,Y~1 ðÞ ~
Pr X ðÞ {Pr XjZ~0,Y~0 ðÞ Pr Z~0,Y~0 ðÞ ,
Xƒargmax
X
Pr XjZ~0,Y~0 ðÞ
ð2Þ
Figure 7. Schematic of empirical Bayes model for single replicate experiments. (A) Example scatter plot of log2 peptide XIC1 versus XIC2
values with colored boxes schematically representing our formulated 3-class model. The green box represents peptides corresponding to small-
molecule-specific target proteins. The majority of ratios (blue box) were clustered along the diagonal of the plot and represent peptides
corresponding to proteins that were pulled down in the experiment but did not bind specifically to the small-molecule. A third group of peptides
(red box) had negative log2 ratio values and were visually separated from the cluster of peptides along the diagonal. These negative ratios were likely
caused by proteins that precipitated out in the light sample due to excess concentration of the soluble competitor small-molecule. (B) The blue curve
represents a histogram of protein ratio values for a k252a experiment performed at .25x concentration (y-axis in log scale, histogram bins with zero
counts are shown as missing data points). The green curve represents the inferred marginal distribution of all data, Pr(X), and the red curve represents
the inferred sub-distribution corresponding to non-targets, Pr(X|Z=0)Pr(Z=0). (C) Using data from the same experiment as in (B), the posterior
probability, Pr(Z=1|X), was plotted as the dotted cyan curve (y-axis linear scale). The blue bars represent a histogram of the data. The red curve
represents the inferred sub-distribution corresponding to non-targets, Pr(X|Z=0)Pr(Z=0), and the green curve represents the inferred sub-
distribution corresponding to targets, Pr(X|Z=1)Pr(Z=1).
doi:10.1371/journal.pone.0007454.g007
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Pr XjZ~1 ðÞ Pr Z~1 ðÞ ~
Pr X ðÞ {Pr XjZ~0,Y~0 ðÞ Pr Z~0,Y~0 ðÞ ,
Xwargmax
X
Pr XjZ~0,Y~0 ðÞ
ð3Þ
and are set to zero for values of X not specified in the arguments of
Eqns. 2 and 3. The proportion of unbound proteins can then be
inferred by integration of the numerator of Eqn. (1):
Pr Z~0 ðÞ ~
ð
Pr XjZ~0 ðÞ Pr Z~0 ðÞ dX ð4Þ
and the proportion of bound proteins is calculate as
Pr Z~1 ðÞ ~1{Pr Z~0 ðÞ .
For replicate experiments we assume that the data are
conditionally independent given the class, Z, and compute the
Bayes posterior probability that a protein is unbound by the test
compound given M SILAC measurements as:
Pr Z~0jX1 ...XM   
~
1
1zP
M
i~1 Pri XijZ~1 ðÞ Pri Z~1 ðÞ
P
M
i~1 Pri XijZ~0 ðÞ Pri Z~0 ðÞ
ð5Þ
where Pri represents the probability model inferred in the i
th
experiment. The probably that a protein is bound by the test
compound given M SILAC measurements is calculated as
Pr Z~1jX1 ...XM   
~1{Pr Z~0jX1 ...XM   
.
Power diagnostics. The probability distributions inferred in
the previous section can be used to reason about the statistical
power of an experiment, defined as the probability that the
experiment will not make a Type II error (i.e. reject a protein that
is truly bound by the small-molecule). In Bayesian terms, a
measure of statistical power is 1 minus the expected local fdr under
the inferred class conditional probability distribution given that the
protein is a target [49]. In our application we compute this
measure of statistical power as:
1{power~E Pr Z~0jX1 ...XM   
Pr X1...XMjZ~1 ðÞ
  
~
ð ?
{?
...
ð ?
{?
Pr Z~0jX1 ...XM    P
M
i~1Pr XijZ~1
  
LX1...LXM
ð6Þ
Gaussian Error Model
To enable direct comparison between our local fdr values and
Benjamini Hochberg tail-area FDR values [51] calculated based
on standard Gaussian error modeling, we transform the tail-area
FDR values to probability estimates at each data point using the
procedure described here. Although derived in a frequentist
context, the Benjamini Hochberg FDR can also be written in
Bayesian form [52]:
FDR x ðÞ ~Pr Z~0jXƒx ðÞ ~
Pr XƒxjZ~0 ðÞ Pr Z~0 ðÞ
Pr Xƒx ðÞ
ð7Þ
The term Pr XƒxjZ~0 ðÞ is the familiar p-value, which we
estimate using a Gaussian error model, and Pr Z~0 ðÞ is set to 1.
The Benjamini Hochberg procedure then estimates the denomina-
tor of Eqn. (7) usingthe empirical CDF, Pr Xƒx ðÞ ~
PN
j~1 gX jvx ðÞ
N ,
where g . ðÞreturns a value of 1 if the argument is true, and zero
otherwise. A local estimate of the false discovery rate for a given
value of Z can then be computed as
fdr x ðÞ ~
Pr Xƒ xzdx ðÞ j Z~0 ðÞ Pr Z~0 ðÞ {Pr XƒxjZ~0 ðÞ Pr Z~0 ðÞ
Pr Xƒ xzdx ðÞ ðÞ {Pr Xƒx ðÞ
ð8Þ
Because the empirical CDF in the Benjamini Hochberg FDR
calculation is only evaluated at the data points, we evaluate Eqn. (8)
using the continuous estimate of Pr X ðÞ described in our formulation
of the empirical Bayes procedure. The calculation is then equivalent
to the local fdr, calculating the null distribution based on a Gaussian
model and setting the prior null probability to 1.
Materials and reagents
L-arginine-13C6 and L-lysine-13C615N2 were from Sigma
Isotec (St. Louis, MO). The cell culture media, Roswell Park
Memorial Institute-1640 (RPMI) deficient in arginine, lysine and
methioine, was a custom media preparation from Caisson
Laboratories (North Logan, UT). All other L-amino acids were
obtained from Sigma. Dialyzed serum was obtained from SAFC-
Sigma. Cell culture reagents were from Invitrogen, unless
otherwise specificed. Trypsin was from Promega (Madison, WI).
All other reagents and chemicals used were of the highest grade
available. HeLa S3 was a kind gift from Dr. James Bradner.
Preparation of affinity matrices
The solid-phase beads used in small-molecule immobilization
and affinity chromatography is Affigel 102 (Bio-Rad) with a
loading level of 12 mmol/mL suspension. Small-molecules used in
this study were: k252a (Biomol, Plymouth Meeting, PA), SB-
202190 (Sigma), and AP-1497 (synthesized in-house [53]). Small-
molecules (1 eq.) in acetonitrile were combined with di(N-
succimidyl)carbonate (3 eq.), before triethylamine (4 eq.) was
added. The reaction solution was stirred at 50uC for 1 h and the
activation efficiency was monitored by LC-MS. The amount of
activated compound was adjusted accordingly and added to
Affigel beads as needed, depletion of free activated bait molecule
was monitored by LC-MS. After immobilization, vials were
centrifuged, the supernatant was removed and the beads were
washed with DMF (362 mL) and H2O (362 mL). The beads
were subsequently suspended in 1x PBS (0.8 mL) and stored at
4uC before use. Beads loaded with 12% compound loading had
approximately 18.5 nmoles of compound with the remaining bead
surface underivatized and bearing the original free amine.
SILAC labeling and affinity enrichments
The suspension cell line, HeLa S3, was grown in RPMI SILAC
labeling media, prepared as previously described [54], supple-
mented with 2 mM L-glutamine, and 5% dialyzed fetal bovine
serum (SAFC-Sigma) plus antibiotics, in a humidified atmosphere
with 5% CO2 in air. Cells were grown for at least 6 cell divisions
in labeling media, and expanded in spinner flasks to obtain about
35 mg protein in each state.
Separate cultures of HeLa S3 cells SILAC labeled either with L-
arginine and L-lysine (light) or L-arginine-13C6 and L-lysine-
13C6-15N2 (heavy) were lysed in ice-chilled ModRIPA buffer (low
stringency buffer LS) containing 1% NP-40, 0.1% Na deoxycho-
late, 150 mM NaCl, 1 mM EDTA, 50 mM Tris, pH 7.5, and
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Indianapolis, IN). Chilled lysates were vortexed intermittently and
clarified by spinning at 14,0006g. Protein concentrations of light
and heavy lysates were equalized using the Protein Assay Dye
Reagent Concentrate (Biorad, Hercules CA).
In soluble competitor experiments, the appropriate amount of
small-molecule (dissolved in DMSO with stocks at 110 nmoles/mL)
was added to 2 mg of light HeLa S3 lysate. An equal volume of
DMSO was then added to 2 mg of heavy HeLa S3 as a control.
25 mL of 50% of small-molecule-bead was added to both light and
heavy pull-down tubes in soluble competitor experiments.
Affinity enrichments were incubated overnight on an end-over-
end rotator at 4uC. Beads were collected by centrifugation at
10006g, and washed twice with ModRIPA buffer before beads
were combined and washed together in the third wash. Proteins
enriched in SILAC affinity pull-downs were reduced and alkylated,
on bead, in 2 mM DTT and 10 mM iodoacetamide respectively
before adding sample buffer and heating at 70uC for 10 minutes.
Proteins were resolved on a 4–12% gradient 1.5 mm thick Bis-Tris
gel with MES running buffer (Nupage, Invitrogen) and Coomassie
stained (Simply Blue, Invitrogen). Gel lanes were excised into 6
pieces and then further cut into 1.5 mm cubes, and proteins
digested overnight with trypsin following standard protocols.
Peptides from each gel slice were extracted with 0.1% TFA and
cleaned up on C18 StageTips [55]. Peptides were eluted in 50 mLo f
80% acetonitrile/0.1% TFA and dried down in a evaporative
centrifuge to remove organic solvents. The peptides were then
resuspended by vortexing in 7 mL of 0.1% TFA and analyzed by
nanoflow-LC/MSwithanAgilent1100 withautosampler(HP,Palo
Alto, CA) and a LTQ-Orbitrap (Thermo, Bremen Germany).
Peptides were resolved on a 10 cm column, made in-house by
packing a self-pulled 75 mm I.D. capillary, 15 mm tip (P-2000 laser
based puller, Sutter Instruments) column with 3 mm Reprosil-C18-
AQ beads (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany)
with an analytical flowrate of 200 nL/min and a 58 min linear
gradient (,0.57%B/min) from 0.1% formic acid in water to 0.1%
formic acid/90% acetonitrile.
MS data pre-processing
We used an MS method with a master Orbitrap full scan
(60,000 resolution) and data dependent LTQ MS/MS scans for
the top 5 precursors (excluding z=1) from the Orbitrap scan.
Each cycle was approximately 2 secs long. MS raw files were
processed for protein identification and quantitation using
extract_msn.exe (Thermo, Bremen Germany), Mascot (Ver.
2.1.03 Matrixscience, London UK), and open-source academic
software, DTASupercharge and MSQuant (CEBI, http://
msquant.sourceforge.net) (Figure S4). MS/MS peak lists in Mascot
Generic Format were generated using extract_msn.exe and
DTASupercharge (ver. 1.17, default settings) and searched with
Mascot using IPI human ver.3.32 (http://ebi.ac.uk) with a
concatenated decoy database containing randomized sequences
from the same database [56]. Common contaminants like bovine
serum albumin, trypsin etc. were also added to the database.
Variable modifications used were oxidized methionine, argini-
ne-
13C6, lysine-
13C6
15N2, and carbamidomethyl-cysteine was a
fixed modification. The precursor mass tolerance used in the
search was 15 ppm and fragment mass tolerance was 0.7 Da. The
Mascot result file in the appropriate format (http://msquant.
sourceforge.net) was parsed by MSQuant with the following
settings: bold and checked red, and parenthesized peptides were
included in the list of preselected peptides, of these, peptides with
score .20 were quantified. Proteins with a minimum Mascot
score of 66 (at least 1 peptide with score .66) were exported to
data files by MSQuant and these text files (included in Data Set
S1) were used as input for our statistical analysis. Only proteins
with a minimum of 2 quantifiable peptides in either replicate
experiment were included in our data set. The false-positive rate
for protein identification was ,1% and ,5% at the peptide level,
as determined using the decoy database strategy.
Supporting Information
Figure S1 Comparison of methods for estimation of the
marginal probability distribution. The plots display the results of
3 different methods for inferring the marginal distribution of log2
protein ratio values from a k252a experiment at 2.5x and 5x
concentrations. Using a seventh-order Poisson regression model
(dotted red curve) (Efron, 2002) yielded an over-fit model of the
tails of the distribution. Other similar methods proposed by (Efron,
2002) (e.g. natural splines) produced highly similar results to the
Poisson regression model. Our density estimation method (green
curve) yielded a more accurate model of the data. We also tested
the ability to fit the data using a T distribution (dotted cyan curve),
but observed that this approach in general produced overly heavy
tails and therefore over-estimated the significance of data points
with high (or low, where applicable) ratio values.
Found at: doi:10.1371/journal.pone.0007454.s001 (0.14 MB
PDF)
Figure S2 Magnitude versus amplitude plot of peptide values of
a k252a experiment performed at .25x concentration. We suggest
that quantitative proteomics datasets should be tested for intensity-
dependent variance in ratio values in order to choose a method of
summarizing values for multiple peptides identifying the same
protein. Because our datasets displayed minimal intensity-
dependent variance, we used the median across peptide values,
but for datasets displaying intensity-dependence we suggest using
an intensity-weighted average instead.
Found at: doi:10.1371/journal.pone.0007454.s002 (0.12 MB
PDF)
Figure S3 Robustness of inferred distributions to inference
parameters. The robustness of inferred distributions to estimation
parameters was demonstrated for an affinity pull-down experiment
performed using k252a at .25x concentration and a miR-16 over-
expression experiment. (a) The class-conditional probability
distribution of log2 SILAC ratio values, Pr(X|Z=0), was
estimated using a fixed-sized window around the central peak of
the data. The size of this window should be chosen such that it
includes few values thought to be significant, although it has been
shown that if Pr(Z=0) ..9, the null distribution can be fit with
negligible bias, even though some values in the window may not
belong to the null distribution (Efron, 2004). The choice of this
parameter may be based on prior knowledge regarding the
expected variability of the experiment, or the percent of proteins
expected to be significant. However, because the central portion of
the data was well modeled by a Gaussian distribution, our results
were robust over a large range of values for this parameter. (b) The
marginal distribution, Pr(X), was modeled using kernel density
estimation with generalized Pareto distributions fit to the tails. The
percent of data used to model the generalized Pareto distributions
should be chosen to reflect the region where the data becomes
sparse and cannot be accurately modeled using kernel density
estimation. In this work we fit the generalized Pareto distributions
from 2.5 to +.5 from the central peak, but have also found that
estimation is extremely robust over a large range of this parameter.
Although we suggest that our parameter choices are reasonable for
other data sets that demonstrate similar experimental variance, an
Empirical Bayes for Proteomics
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these parameters in an experiment-specific manner, for example
by testing for deviations from normality to estimate the null
distribution, or by testing for data sparsity to estimate the marginal
distribution. In the current work, our suggested heuristics appear
to perform well, with the inference results being robust to different
choices for these parameters.
Found at: doi:10.1371/journal.pone.0007454.s003 (0.13 MB
PDF)
Figure S4 SILAC target ID data pre-processing workflow.
Found at: doi:10.1371/journal.pone.0007454.s004 (0.09 MB
PDF)
Figure S5 microRNA seed enrichments compared to predicted
local fdrs for different parameter choices and binding site
definitions. Each plot (A–F) corresponds to Figure 6a from the
main text. (A–E) Seed enrichments were calculated based on 4
alternate binding site definitions, as used by (Selbach et al, 2008),
as well as using predicted targets from the Target Scan database
(Lewis et al, 2005), and using a bin size of 100 proteins. (F) The
result from Figure 6a in the main text was reproduced using a
background size of one-fifth rather than one-third.
Found at: doi:10.1371/journal.pone.0007454.s005 (0.25 MB
PDF)
Table S1 Small-molecule target identification. This table
contains lists of target proteins inferred in each affinity pull-down
experiment. The 3 first pages each present the results from 1 of the
analysis methods described in our study. For each experiment
(listed in the first row), we provide a list of proteins identified as
targets, followed by 2 columns of binary numbers listing whether
the protein is a known target or a secondary interactor, followed
by a ‘‘Notes’’ column annotating any additional evidence
suggesting that an unknown target may in fact interact with the
tested small-molecule. The fourth page provides a summary of the
results of each analysis method, with predictions evaluated with
respect to our lists of known targets.
Found at: doi:10.1371/journal.pone.0007454.s006 (0.07 MB
XLS)
Table S2 microRNA statistics. This table contains a statistical
description of each microRNA experiment, based on the empirical
Bayes model. A description of each data column is included in the
table.
Found at: doi:10.1371/journal.pone.0007454.s007 (0.04 MB
XLS)
References S1 List of publications referenced in the supple-
mentary figure and table legends.
Found at: doi:10.1371/journal.pone.0007454.s008 (0.07 MB
PDF)
Data Set S1 MSQuant output files for small-molecule target
identification experiments analyzed in this study.
Found at: doi:10.1371/journal.pone.0007454.s009 (38.94 MB
ZIP)
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